No Difference In Ketoconazole Response For Men With Advanced Prostate Cancer Post Chemotherapy Failure

The use of Ketoconazole (Keto) in men with advanced prostate cancer is not considered mainstream, however there is clear evidence that it does reduce PSA in men with castrate resistant prostate cancer. Currently, most men with advanced prostate cancer who do use Keto utilize it prior to chemotherapy. There has been little literature evaluating the [...]

Caregivers of People Treated By the VA Can Qualify for Benefits

In July the Department of Veterans Affairs (VA) sent out the first stipend payments to nearly 100 family caregivers of veterans, including men with prostate cancer. To qualify for the benefits the caregivers first had to complete a training program, “Comprehensive Assistance for Family Caregivers”. Qualified family caregivers receive an average $1,600 in monthly stipend [...]

Request for the Approval of Denosumab to Protect Bones in Men with Advanced Prostate Cancer

Amgen has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the indication for denosumab (XGEVA) its RANK ligand inhibitor to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases. Although some doctors have already begun to use Xgeva in men with advanced prostate cancer, it is [...]

An Important Note for Residents of New York State -Ask Governor Cuomo to Sign the Oral Chemotherapy Equity Bill

There is some good news; the New York State Legislature has passed the Oral Chemotherapy Equity Bill. However, before this bill can become law we have to have Governor Cuomo sign it, we need all of our New York Residents to contact the governor and ask that he signs it. […]

Go to Top